Znanstveni rad - Izvorni znanstveni rad
Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral‐naïve persons starting treatment
HIV Medicine, 21 (2020), 9; 599-606. https://doi.org/10.1111/hiv.12888

Mocroft, A; Neesgard, B; Zangerle, R; Rieger, A; Castagna, A; Spagnuolo, V; Antinori, A; Lampe, FC; Youle, M; Vehreschild, JJ; Mussini, C; Borghi, V; Begovac, Josip; Duvivier, C; Gunthard, HF; Rauch, A; Tiraboschi, J; Chkhartishvili, N; Bolokadze, N; Wit, F; Wasmuth, JC; De Wit, S; Necsoi, C; Pradier, C; Svedhem, V; Stephan, C; Petoumenos, K; Garges, H; Rogatto, F; Peters, L; Ryom, L Više autora...

Citirajte ovaj rad

Mocroft, A., Neesgard, B., Zangerle, R., Rieger, A., Castagna, A., Spagnuolo, V. ... Ryom, L. (2020). Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral‐naïve persons starting treatment. HIV Medicine, 21. (9), 599-606. doi: 10.1111/hiv.12888

Mocroft, A, et al. "Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral‐naïve persons starting treatment." HIV Medicine, vol. 21, br. 9, 2020, str. 599-606. https://doi.org/10.1111/hiv.12888

Mocroft, A, B Neesgard, R Zangerle, A Rieger, A Castagna, V Spagnuolo, A Antinori, et al. "Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral‐naïve persons starting treatment." HIV Medicine 21, br. 9 (2020): 599-606. https://doi.org/10.1111/hiv.12888

Mocroft, A., et al. (2020) 'Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral‐naïve persons starting treatment', HIV Medicine, 21(9), str. 599-606. doi: 10.1111/hiv.12888

Mocroft A, Neesgard B, Zangerle R, Rieger A, Castagna A, Spagnuolo V, i sur.. Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral‐naïve persons starting treatment. HIV Medicine [Internet]. 26.06.2020. [pristupljeno 17.05.2022.];21(9):599-606. doi: 10.1111/hiv.12888

A. Mocroft, et al., "Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral‐naïve persons starting treatment", HIV Medicine, vol. 21, br. 9, str. 599-606, Lipanj 2020. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:601886. [Citirano: 17.05.2022.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.